Medicinski fakultet sveučilišta u splitu jasna Ajduković

9.0. Literatura

1. Lazarus JM, Brenner BM. Chronic renal failure. U: Fauci Asi sur.,

urednici.Harrison's principles of internal medicine. New York: Mc Graw-Hill;
1998. str.1513-24.
2. Zawada ET, Jr, Indications for Dialysis. U: Daugirdas JT, Ing TS, urednici.
Handbook of Dialysis. Boston: Little, Brown and Company; 1994: 3-9.
3. Gašparović V.Kronično zatajenje bubrega. U: Hadžić N, Radonić M,

Vrhovac B, Vucelić B i sur., urednici. Priručnik interne medicine:

dijagnostika i terapija. Zagreb: Školska knjiga ;1989: 352- 359.

4. Duraković Z, Gašparović V, Ivanović D, Radošević-Stašić B. Bubrežna

insuficijencija. U: Gamulin S, Marušić M, Kovač Z, urednici.
Patofiziologija. Zagreb: Medicinska naklada; 2002. str. 877-85.
5. Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for
chronic kidney disease: evaluation, classification, and stratification. Web dokument. Dostupno na URL:
http:// www.guideline/gov/summary/summary.aspx?ss (zadnji pristup rujan 2004.)
6. Kidney Disease Outcomes Quality initiative. Clinical practice guidelines for bone
metabolism and disease in chronic kidney disease. Web dokument. Dostupno na URL:
http://www.kidney.org/professionals/kdoqi/guidelines_bone/guide 5. htm (zadnji pristup
08.11.2004.)
7. Lee YS. Ultrastructural observations of chronic uremic lungs with special reference to
histochemical d X-ray microanalytic studies on altered alveolocapillary basement
membranes. Am J Nephrol 1985;5:255-66.
8. Van Stone JC, Daugirdas JT. Physiologic Principles. U: Daugirdas JT,
Ing TS, urednici. Handbook of Dialysis. Boston: Little, Brown and
Company; 1994:13-28.
9. Dialysis and filtration procedures. U: Berkow R, Fletcher AJ, urednici.
The Merc Manual of diagnosis and therapy.Rahway: Merc & Co Inc.;
1992. str 1668-71.
10. Dujic Z, Tocilj J, Ljutic D, Eterovic D. Effects of hemodyalisis and

anemia on diffusing capacity, membrane diffusing capacity and capillary

blood volume in Uremic patients. Respiration 1991; 58: 277-81.
11. Schreiner GE: The search for uremic toxin(s). Kidnex Int 1975; 7:
270-3.
12. Bergstrom J, Furst P, Zimmerman L:Uremic middle molecules exist
and are biologically active. Clin Nephrol 1979; 11: 229-33.
13. Sonikian M, Gogusev J, Zingraff J, Loric S, Quednau B, Bessou G
i sur. Potential effect of metabolic acidosis on b2- microglobulin
generation:In vivo and in vitro studies. J Am Soc Nephrol 1996; 7:
350-6.
14. Asaba H, Furst P, Oules R, Waad M, Yahiel V, Zimmerman L i sur.
The effect of hemodialysis on endogenous middle molecules in uremic
patients. Clin Nephrol 1979;11:257-62.
15. De Smet R, Glorieux G, Hsu C, Vanholder R. p-Cresol and uric acid:
Two old uremic toxins revisited. Kidney Int 1997; 51(Supl 1): 8-11.
16. Maddock AL, Westenfelder C. Urea induces the heat shock response
in human neuroblastoma cells. J Am Soc Nephrol 1996; 7:275-82.
17. Giovanetti S, Barsotti G: Dialysis of methylguanidine. Kidney Int 1974; 6: 177-82.
18. Sorkin MI, Diaz- Buxo JA. Physiology of Peritoneal Dialysis. U:
Daugirdas JT, Ing TS, urednici. Handbook of Dialysis . Boston: Little,
Brown and Company;1994: 13-28.
19. Evans SE, Scanlon PD. Current Practice in Pulmonary Function
Testing. Mayo Clin Proc 2003; 78: 758-63.
20. Pulmonary disorders. U: Berkow R, Fletcher AJ, urednici. The Merc

Manual of diagnosis and therapy. Rahway: Merc & Co ; 1992. str.

607-20.
21. Weinberger SE, Drazen JM. Disturbances of respiratory function. U :
Fauci AS et al., urednici. Harrison's Principles of Internal Medicine. New
York: Mc Graw-Hill;1998: 1410-13.
22. Bakran I, Žuškin E. Poremećaji disanja. U : Gamulin S, Marušić M,
Kovač Z, urednici. Patofiziologija. Zagreb: Medicinska naklada; 2002. str.
833-56.
23. Vijayasekaran D, Subramanyam L, Balachandran A, Shivbalan S.

Spirometry in Clinical Practice. Indian Pediatrics 2003; 40: 626-32.

24. Simpozij o difuzijskom kapacitetu pluća, Zbornik radova. Split 1988
25. Roughton FJW, Forster RE. Relative importance of diffusion and
chemical reaction rates in determing rate of exchange of gases in the
human lung, with special reference to true diffusing capacity of
pulmonary membrane and volume of blood in the lung capillaries. J
Appl Physiol 1957; 2: 290-302.
26. Hughes JMB. The single breath transfer factor (TLCO) and the trnsfer
coefficient (KCO): a window onto the pulmonary microcirculation. Clin
Physiol Func Im 2003; 23: 63-71.
27. Kaupke CJ, Vaziri ND. Lungs and Pleura. U: Daugirdas JT, Ing TS,
urednici. Handbook of Dialysis. Boston: Little, Brown and Company; 1994; 599-
03.
28 . Cohen M, Sahn SA. Resolution of Pleural effusions. Chest 2001; 119: 1547-62.
29. Lee HY, Stretton TB, Barnes AM. The lungs in renal failure. Thorax
1975;30:46-53.
30. Wanic- Kossowska M. Ventilation and gas excange in patients with
chronic renal failure treated with hemodialysis (HD) and intermittent
peritoneal dialysis (IPD). Pol Arch Med Wewn 1996; 96: 442-50.
31. Bush A, Gabriel R. The lungs in uraemia: a review. J R Soc Med 1985; 78: 849-855.
Vanholder R, De Smet R, Glorieux G, Dhondt A. Survival of
Hemodialysis Patients and Uremic Toxin Removal. Artificial Organs
2003; 27: 218-223.
32. Herrero JA, Alvarez-Sala JL, Coronel F, Moratilla C, Gamez C,
Sanchez-Alarcos JM, Barrientos A. Pulmonary diffusing capacity in
chronic dialysis patients. Respir Med 2002;96: 487-92.
33. Conte JV, Ferber LR, Borja M, Alexander C, May E, Yang S, Orens
JB. Lung transplantation from Dialysis Dependent Donors. J Heart Lung
Transplant 2000; 19: 894-96.
34. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office Spirometry
for Lung Health Assessment in Adults: A consensus steatment from the
National Lung Health Education Program. Chest 2000; 117: 1146-61.
35. O´Donnell DE. Assessment of Bronchodilatator Efficacy in
Symptomatic COPD Is Spirometry Useful?. Chest 2000; 117: 42S-47S.
36. Celli BR. Importance of Spirometry in COPD and Asthma. Chest
2000; 117: 15S-19S.
37. Enright PL, Kaminsky DA. Strategies for Screening for Chronic
Obstructive Pulmonary Disease. Respir Care 2003; 48: 1194- 00.

38. Enright PL. How to make sure your spirometry test are of good

quality. Respir Care 2003; 48: 773-76.
39. Qudrelli SA, Roncorni A. Features of Asthma in the Elderly. Journal
of Asthma 2001; 38: 377-89.
40. Goldbllum SE, Reed WP. Host defenses and immunologic
alterations associated with Chronic hemodyalisis. Ann Intern Med
1980;93:597-613
41. Putnam JS. The effect of hemodyalisis on lung function, gas
excange, an response to carbon dioxide stimulation in chronic uremia.
Am J Med Sci 1977;273:87-93.
42. Myers BD, Rubin AE, Schey G, Bruderman I, Pokroy NR, Levi J.
Functional Characteristics of the lung in chronic uremia treated by renal
dialysis therapy. Chest 1975;68:191-194.
43. Foley RN, Parfrey PS, Harnett JD, Kent GM,Martin CJ, Murray DO
et al.Clinical and echocardiographic disease in patients starting
endstage renal disease therapy. Kidney Int.1995;47:186-92.
44. Crapo RO, Morris AH, Gardner RM. Reference values for pulmonary
tissue volume, membrane diffusing capacity,and pulmonary capillary
blood volume. Bull Eur Physiopathol Respir1982;18:893-93.

45. Patterson RW, Nissenson AR, Miller J,Smith RT, Narins RG,

Sulivan SF. Hypoxemia and pulmonary gas excange during
hemodyalisis. J Appl Physiol 1981;50:259-264.
46. Ewert R, Opitz C, Wensel R, Dandel M, Mutze S, Reinke P.
Abnormalities of Pulmonary Diffusion Capacity in Long-term Survivors
After KidneyTransplantation. Chest 2002; 122: 639-44.
47. Calverley P, Bellamy D. The chalenge of providing helth care for
patients with chronic. obstructive pulmonary disease: the poor relation of
airways obstruction. Thorax 2000; 55: 78-82.
48. Pride NB. Smoking cessation and lung function in mild to moderate
chronic obstructive pulmonary disease. Thorax 2001: 56(supl II) 7-
10.
49. Hsia CCW. Recruitment of Lung Diffusing Capacity Update of
Concept and Application. Chest 2002; 122: 1774- 83.
50. Jensen RL, Crapo RO. Diffusing Capacity: How to get it right.
Respir Care 2003; 48: 777-82.
51. Johnson RL. Gas Exchange Efficiency in Congestive Heart Failure.
Circulation 2000; 101: 2774-76.
52. Owen WF. Patterns of care for Patients with Chronic Kidney Disease
in the United States: Dying for Improvement. J Am
Soc Nephrology 2003; 14: S76-S80.
53. Buemi M, Aloisi C, Cutroneo G, Nostro L, Favaloro A. Flowing time
on the peritoneal membrane. Nephrol Dial Transplant 2004; 19: 26-29.
54. Dyadyk OI, Bagriy AE, Yarovaya NF. Disorders of left ventricular
structure and function in chronic uremia: how often, why and what to do
with it?. Europian Journal of Heart Failure 1999; 1: 327-36.
55. Stigant C, Stevens L, Levin A. Nephrology: strategies for the care of
adults with chronic kidney disease. CMAJ 2003; 168: 1553-60.
56. Delgado DS, Gerola LR, Hossne NA, Branco JNR, Buffolo E.
Myocardial Revascularisation in Renal transplant Patients. Arq Bras
Cardiol 2002; 79: 480-3.
57. Mashour S, Turner JF, Merell R. Acute Renal Failure, Oxalosis, and
Vitamin C Supplementation. Chest 2000; 118. 561-63.
58. Robinson TG, Carr S. Cardiovascular autonomic dysfunction in
uremia. Kidney Int 2002; 62: 1921-32.
59. Martin KJ, Olgaard K. Diagnossis, assessment, and Treatment of
Bone Turnover Abnormalities in Renal Osteodystrophy. A J

Kid Dis 2004; 43: 558-65.

60. Aproaches to the Reversal of Malnutrition, Inflammation, and
Atherosclerosis in End-Stage Renal Disease. Nutrition Reviews 2002;
60: 378-87.
61. Hamilton RW, Epstein PE, Henderson LW, Edelman NH, Fishman
AP. Control of Breathing in uremia: ventilatory response to CO2 after
hemodialysis. J Appl Physiol1976;41:216-222.
62. Vanholder R, De Smet R, Glorieux G, Dhondt A. Survival of
Hemodialysis Patients and Uremic Toxin Removal. Artificial Organs
2003; 27: 218-223.